Showing results (11-20 of 120) with videos related to

Sort By:
Pageof 12
Nature Communications|February 17, 2021
Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cellsRebekka Duhen, Carmen Ballesteros-Merino, Alexandra K Frye, et al.
Cancer Research|July 19, 2002
Development of antitumor immune responses in reconstituted lymphopenic hostsHong-Ming Hu, Christian H Poehlein, Walter J Urba, et al.
International Journal of Surgical Pathology|June 25, 2008
Histopathologic and molecular aspects of CD56+ natural killer/ T-cell lymphoma of the testisDeborah L Ornstein, Carlo B Bifulco, Demetrios T Braddock, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|November 8, 2006
Polychromatic flow cytometry: a rapid method for the reduction and analysis of complex multiparameter dataUlf Petrausch, Daniel Haley, William Miller, et al.
Clinical & Experimental Metastasis|November 24, 2004
Regression of bone metastases following adoptive transfer of anti-CD3-activated and IL-2-expanded tumor vaccine draining lymph node cellsDominik Rüttinger, Rui Li, Walter J Urba, et al.
Human Pathology|July 8, 2008
Different cytokeratin and neuronal cell adhesion molecule staining patterns in focal nodular hyperplasia and hepatic adenoma and their significanceAnita Iyer, Marie E Robert, Carlo B Bifulco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2009
Characterization of the class I-restricted gp100 melanoma peptide-stimulated primary immune response in tumor-free vaccine-draining lymph nodes and peripheral bloodEdwin B Walker, William Miller, Daniel Haley, et al.
Clinical Genitourinary Cancer|October 10, 2009
Safety and efficacy of PF-3512676 for the treatment of stage IV renal cell carcinoma: an open-label, multicenter phase I/II studyJohn A Thompson, Timothy Kuzel, Beverly J Drucker, et al.
Clinical Breast Cancer|March 7, 2003
Allogeneic breast cancer cell vaccinesAnnemieke Dols, Sybren L Meijer, John W Smith, et al.
The Oncologist|April 26, 2022
PCM1-JAK2 Fusion Tyrosine Kinase Gene-Related Neoplasia: A Systematic Review of the Clinical LiteratureHenry G Kaplan, Ruyun Jin, Carlo B Bifulco, et al.
Pageof 12